Human Longevity
About Human Longevity
Human Longevity provides comprehensive executive health and longevity programs featuring precision diagnostics, proactive preventive care, and early disease detection. The organization operates across multiple locations in the United States with a focus on personalized, data-driven healthcare to extend healthspan and lifespan. Its care ecosystem emphasizes genome sequencing, multimodal diagnostics, and proactive cancer prevention, anchored by a commitment to long-term health data and research. Based in the Bay Area with San Diego and Beijing partner sites, it positions itself as a leader in preventive longevity and advanced medical genetics.
Recent News
Insilico Medicine, Human Longevity Partner for Longevity Foundation Model
Human Longevity Rolls Out $599 Clinical‑Grade Whole‑Genome Sequencing with AI Health Insights
Swiss Study Finds 37‑Protein Signature That Sets Centenarians Apart
Genomics Pioneer J. Craig Venter Dies, Leaving a Data‑Driven Legacy
Tony Robbins Opens AI-Powered Fountain Life Clinic in Houston
Monday's TechBio News
Whole Genome Sequencing
Longevity Science Picks up Steam in Pharma
Schneider Shorts 8.05.2026 – Incredible Future Is Now Becoming Reality
Insilico and Human Longevity Launch Multimillion‑dollar AI Eye‑scan to Flag Disease Years Early
Genomics Pioneer J. Craig Venter Dies at 79, Sparking Reflection on Synthetic Biology’s Future
J. Craig Venter: The American Scientist Who Changed Biotech
Recent Deals
No recent deals for this company.